Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2003
03/18/2003US6534495 Anticoagulants that prevent thrombin-related diseases.
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534481 Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534276 Methods for detecting human tissue factor inhibitor
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534093 Immediate release eplerenone compositions
03/18/2003US6534035 Methods of inhibiting clot formation
03/18/2003CA2360311C Improved dialysis solutions and methods
03/18/2003CA2165694C Erythropoietin analogs
03/18/2003CA2139652C Thrombin-inhibitors
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020767A2 Antibodies against caspase-8, their preparation and use
03/13/2003WO2003020764A2 Modified factor ix
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
03/13/2003WO2003020752A1 A peptide and the pharmaceuticals containing it
03/13/2003WO2003020746A1 Modified transferrin fusion proteins
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020325A2 Methods for sterilizing preparations containing albumin
03/13/2003WO2003020324A2 Methods for sterilizing preparations of digestive enzymes
03/13/2003WO2002095006A3 Muscle-specific expression vectors
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
03/13/2003WO2002074291A3 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
03/13/2003WO2002072543A3 Rxr activating molecules
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002066427A3 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/13/2003WO2002046213A3 Methods and reagents for isolating angiogenic modulators
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002023190A3 Methods and products related to low molecular weight heparin
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003WO2001096598A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
03/13/2003US20030050466 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer or autoimmune diaseses
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050299 An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050269 Polynucleotides and polypeptides of the erythropoietin gene
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030049851 Diagnosing blood disorders in humans; obtain blood sample, incubate with test reaagent, monitor precipates, evaluate for blood disorder
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049232 Administering mixture of red blood cells and hemoglobin solution
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2459413A1 Methods for sterilizing preparations containing albumin
03/13/2003CA2458985A1 Antibodies against caspase-8, their preparation and use
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/13/2003CA2457429A1 Modified factor ix
03/12/2003WO2002024654A1 Amino heterocyclic compounds (factor xa inhibitors 14)
03/12/2003EP1291430A1 Ceramide kinase and dna encoding the same
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291341A1 Compounds exhibiting thrombopoietin-like activities
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290175A1 Scramblase 2
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290010A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289992A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289985A2 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289953A1 Serine protease inhibitors
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289941A1 Carbamic acid esters as inhibitors of factor xa
03/12/2003EP1289939A1 Phenylglycine derivatives
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289552A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289536A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
03/12/2003EP1289496A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
03/12/2003EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors
03/12/2003EP0942899B1 Manufacturing process of metoprolol
03/12/2003EP0934064B1 Thrombin inhibitors
03/12/2003EP0907372B1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003CN1402793A Lentiviral triplex DNA, and vectors and recombinant cells contg. same
03/12/2003CN1402788A 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402729A Polycycloalkylpurines as adenosine receptor antagonists
03/12/2003CN1402641A Pharmaceutical compositions of fibrinolytic agent
03/12/2003CN1402639A Pharmaceutical combinations
03/12/2003CN1401662A Anticoagulation and thrombolytic thrombus target fusion mA5UKB
03/12/2003CN1401388A Child 'Xuebao' chewing tablet and preparing process thereof
03/12/2003CN1401372A Antiinflammatory hemostatic gynecologic medicine and use thereof
03/12/2003CN1401353A Chinese medicinal herbs preparation 'Shuzetong' for treating hydrops
1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 671